Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Sale | 2021-12-01 7:07 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 441,290 | $3.9297 | $1,734,150 | 9,607,934 (Indirect) | View |
| 2021-11-23 Sale | 2021-11-26 1:02 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Exit Filing | 921,336 | $11.25 | $10,368,236 | 0 (Indirect) | View |
| 2021-11-18 Sale | 2021-11-22 5:26 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 838,664 | $7.7509 | $6,500,411 | 921,336 (Indirect) | View |
| 2021-11-17 Sale | 2021-11-19 4:38 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S CEO 10% Owner | 2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) | View |
| 2021-05-27 Purchase | 2021-06-01 6:42 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 245,020 | $4.4719 | $1,095,693 | 10,049,224 (Indirect) | View |
| 2021-05-24 Purchase | 2021-05-26 4:56 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 398,714 | $3.9571 | $1,577,731 | 9,804,204 (Indirect) | View |
| 2020-12-21 Purchase | 2020-12-23 4:41 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S CEO 10% Owner | 275,784 | $15.16 | $4,181,208 | 15,514,566 (Indirect) | View |
| 2020-11-04 Purchase | 2020-11-06 4:47 pm | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 1,436,675 | $17.3 | $24,849,231 | 1,760,000 (Indirect) | View |
| 2020-09-28 Purchase | 2020-09-30 4:01 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 110,882 | $13.13 | $1,456,408 | 15,238,782 (Indirect) | View |
| 2020-09-04 Purchase | 2020-09-09 6:55 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 278,369 | $3.9402 | $1,096,829 | 9,405,490 (Indirect) | View |
| 2020-08-28 Purchase | 2020-09-01 08:17 am | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 1,052,631 | $14.25 | $14,999,992 | 15,127,900 (Indirect) | View |
| 2020-08-12 Purchase | 2020-08-14 4:49 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 431,647 | $3.7185 | $1,605,100 | 9,127,121 (Indirect) | View |
| 2020-06-02 Purchase | 2020-06-04 6:26 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 615,129 | $4.9054 | $3,017,479 | 8,695,474 (Indirect) | View |
| 2020-01-30 Purchase | 2020-02-03 5:02 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 169,770 | $6.756 | $1,146,968 | 8,080,345 (Indirect) | View |
| 2020-01-09 Purchase | 2020-01-13 5:59 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 2,971,682 | $5.8669 | $17,434,468 | 7,910,575 (Indirect) | View |
| 2019-10-04 Purchase | 2019-10-07 5:18 pm | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 285,714 | $17.5 | $4,999,995 | 5,821,098 (Indirect Direct) | View |
| 2019-06-26 Purchase | 2019-06-28 4:01 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 769,231 | $26 | $20,000,006 | 14,075,269 (Indirect) | View |
| 2019-06-14 Purchase | 2019-06-18 9:43 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 50,000 | $26.15 | $1,307,546 | 13,306,038 (Indirect) | View |
| 2019-06-06 Purchase | 2019-06-10 7:15 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 76,308 | $27.36 | $2,087,457 | 13,256,038 (Indirect) | View |
| 2019-06-03 Purchase | 2019-06-05 5:41 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 93,692 | $24.92 | $2,335,217 | 13,179,730 (Indirect) | View |
| 2019-03-07 Purchase | 2019-03-11 5:42 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 140,000 | $18.26 | $2,556,316 | 13,086,038 (Indirect) | View |
| 2019-01-07 Purchase | 2019-01-09 9:54 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 1,300,000 | $5.3733 | $6,985,285 | 4,938,893 (Indirect) | View |
| 2018-12-27 Purchase | 2018-12-31 5:17 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 63,700 | $13.11 | $835,107 | 12,946,038 (Indirect) | View |
| 2018-12-20 Purchase | 2018-12-26 6:21 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 60,000 | $12.6 | $755,857 | 12,882,338 (Indirect) | View |
| 2018-12-14 Purchase | 2018-12-18 5:58 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 40,000 | $14.67 | $586,639 | 12,822,338 (Indirect) | View |
| 2018-12-11 Purchase | 2018-12-13 8:18 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 20,000 | $15.6 | $312,073 | 12,782,338 (Indirect) | View |
| 2018-12-06 Purchase | 2018-12-10 6:24 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO 10% Owner | 20,000 | $14.79 | $295,864 | 12,762,338 (Indirect) | View |
| 2018-11-27 Purchase | 2018-11-29 4:34 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G CEO 10% Owner | 3,063 | $15.64 | $47,912 | 12,742,338 (Indirect) | View |
| 2018-11-21 Purchase | 2018-11-26 7:49 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G CEO 10% Owner | 16,937 | $15.29 | $259,017 | 12,739,275 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-12 Option Award | 2022-01-14 4:05 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-12-10 Option Award | 2021-05-04 7:51 pm | N/A 2030-12-10 | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-12-31 Ownership | 2021-02-16 4:18 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Former Director | 2,120,299 | $0 | 3,445 (Indirect) | View |
| 2020-12-31 Ownership | 2021-02-16 4:18 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Former Director | 0 | $0 | 3,445 (Indirect) | View |
| 2020-11-04 Ownership | 2020-11-06 4:47 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 323,325 (Indirect) | View |
| 2019-12-31 Ownership | 2020-02-14 4:02 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 1,001,205 | $0 | 5,038,491 (Indirect) | View |
| 2019-12-31 Ownership | 2020-02-14 4:02 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 0 | $0 | 5,038,491 (Indirect) | View |
| 2019-12-20 Option Award | 2019-12-23 4:05 pm | N/A 2029-12-20 | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-23 4:02 pm | N/A 2029-12-19 | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2018-12-31 Ownership | 2019-02-14 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 500,000 | $0 | 3,638,893 (Indirect) | View |
| 2018-12-31 Ownership | 2019-02-14 4:02 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 46,265 | $0 | 5,774,384 (Indirect) | View |
| 2018-12-31 Ownership | 2019-02-14 4:02 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director | 0 | $0 | 5,774,384 (Indirect) | View |
| 2019-01-23 Option Award | 2019-01-25 6:15 pm | N/A 2029-01-23 | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 12,000 | $0 | 12,000 (Direct) | View |
| 2018-12-15 Option Award | 2018-12-18 5:57 pm | N/A 2028-12-15 | HERON THERAPEUTICS Inc | HRTX | TANG KEVIN C Director 10% Owner | 17,000 | $0 | 17,000 (Direct) | View |